Advertisement

Cytotechnology

, Volume 45, Issue 3, pp 101–106 | Cite as

BHK 21 C13 cells for Aujeszky’s disease virus production using the multiple harvest process

  • Višnja Gaurina Srček
  • Stanislav Čajavec
  • Davor Sladić
  • Zlatko KniewaldEmail author
Article

Abstract

Production of Aujeszky’s disease virus (ADV) from BHK 21 C13 suspension cells using a simple harvest and multiple harvest process mode was examined. We studied growth kinetics of BHK 21 C31 cells in 750 ml spinner flask containing 500 ml of culture medium. In the simple harvest process of ADV production, 425 ml of virus harvest was obtained with a virus titer of 106.4 TCID50 ml−1 which corresponds to 10,676 doses of vaccine. The multiple harvest process resulted in 850 ml of virus harvest with a virus titer of 106.5 TCID50 ml−1 corresponding to 26,877 AD vaccine doses. In conclusion, the multiple harvest process mode using BHK 21 C13 can be considered as a favorable process to produce ADV.

Keywords

Aujeszky’s disease virus Baby hamster kidney cells Biomass production Multiple harvest process Spinner flask 

Abbreviation

ADV

Aujeszky’s disease virus

AD

Aujeszky’s disease

BHK 21

Baby Hamster Kidney cells

TCID50

Tissue Culture Infectious Dose 50

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Afsahar, A., Dulac, G.C. 1986Immunoperoxidase plaque staining for the detection of pseudorabies virusCan. J. Vet. Res.50118119PubMedGoogle Scholar
  2. Baijot, B., Duchene, M., Stephenne, J. 1987Production of Aujeszky vaccine by the microcarrier technology “From the ampoule to the 500 l fermentor”Develop. Biol. Stand.66523530Google Scholar
  3. Butler, M., Spier, R.E. 1984The effects of glutamine utilization and ammonia production on the growth of BHK cells in microcarriers cultureJ. Biotechnol.1187196CrossRefGoogle Scholar
  4. Cruz, H.J., Freitas, C.M., Alves, P.M., Moreira, J.L., Carrondo, M.J.T. 2000Effects of ammonia and lactate on growthmetabolismand productivity of BHK cellsEnz. Microb. Technol.274352CrossRefGoogle Scholar
  5. Gümüşdereliouğlu, M., Aslankaraoglu, E., Gürhan, S.I. 2001Rabies vaccine production in non-woven polyester fabric (NWPF) packed-bed reactorsBiotechnol. Appl. Biochem.33167172CrossRefPubMedGoogle Scholar
  6. Kallel, H., Jouini, A., Majoul, S., Rourou, S. 2002Evaluation of various serum and animal protein free media for the production of veterinary rabies vaccine in BHK-21 cellsJ. Biotechnol.95195204CrossRefPubMedGoogle Scholar
  7. Lojkić, M., Markuš-Cizelj, L.J., Čajavec, S., Zidar, V., Gojšić, S. 1992Investigation on safety of attenuated Aujeszky’s disease vaccine (Ay-Vak Bartha-6) in piglets and sowsPraxis veterinaria40315322Google Scholar
  8. Markuš-Cizelj, L.J., Lojkić, M., Čajavec, S. 1991Immunogenicity of an inactivated oil gI negative Aujeszky’s disease vaccine (Davak gE-)Praxis veterinaria392735Google Scholar
  9. Merten, O.-W., Hannoun, C., Manuguerra, J.-C., Ventre, F., Petres, S. 1996Production of influenza virus in cell cultures for vaccine preparationCohen, S.Shafferman, A. eds. Novel Strategies in Design and Production of VaccinesPlenum PressNew York, USA141151Google Scholar
  10. Merten, O.-W., Wu, R., Couvé, E., Crainic, R. 1997Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactorsCytotechnology253544CrossRefGoogle Scholar
  11. Merten, O.-W., Kallel, H., Manuguerra, J.-C., Tardy-Panit, M., Crainic, R., Delpeyroux, F., der Werf, S., Perrin, P. 1999The new medium MDSS2Nfree of any animal protein supports cell growth and production of various virusesCytotechnology30191201CrossRefGoogle Scholar
  12. Mettenleiter, T.C. 2000Aujeszky’s disease (pseudorabies) virus: the virus and molecular pathogenesis-state of the artJune 1999Vet. Res.3199115CrossRefPubMedGoogle Scholar
  13. Perrin, P., Madhusudana, S., Gontier-Jallet, C., Petres, S., Tordo, N., Merten, O.W. 1995An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor systemVaccine1312441250CrossRefPubMedGoogle Scholar
  14. Puentes, E., Eiras, A., Cancio, E., Nores, M.V., Aquilera, A., Seoane, R., Regueiro, B.J. 1993Comparison of the protective efficacy of Aujeszky’s disease (pseudorabies) virus glycoproteins obtained from different sourcesVet. Microbiol.354559CrossRefPubMedGoogle Scholar
  15. Radlett, P.J., Pay, T.W.F., Garland, A.J.M. 1985The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year periodDevelop. Biol. Standard.60163170Google Scholar
  16. Zuckermann, F.A. 2000Aujeszky’s disease virus: opportunities and challengesVet. Res.31121131CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Višnja Gaurina Srček
    • 1
  • Stanislav Čajavec
    • 2
  • Davor Sladić
    • 3
  • Zlatko Kniewald
    • 1
    Email author
  1. 1.Faculty of Food Technology and BiotechnologyUniversity of ZagrebZagrebCroatia
  2. 2.Veterina Ltd.KalinovicaCroatia
  3. 3.PLIVA Inc.ZagrebCroatia

Personalised recommendations